Valuation : GC Corp.

Market Cap 449B 331M 285M 269M 245M 458M 31.24B 461M 3.18B 1.23B 15.97B 1.24B 1.21B 52.46B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,843B 1.36B 1.17B 1.1B 1B 1.88B 128B 1.89B 13.06B 5.07B 65.54B 5.1B 4.98B 215B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
1 day-1.20%
1 week-1.89%
Current month-1.79%
1 month+5.91%
3 months-18.66%
6 months-38.17%
Current year-38.13%
1 week 9,850
Extreme 9850
10,320
1 month 9,130
Extreme 9130
11,050
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
34,800
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 2010-02-28
Chief Executive Officer 72 2010-03-24
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 2010-12-16
Director/Board Member 76 2009-02-28
Director/Board Member 52 2010-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
4/25/25 Buy

Chief Executive Officer

1,334 0.0028%
4/25/25 Buy

Chief Executive Officer

3,191 0.0068%
4/25/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-1.89%-33.31%-29.29% 331M
+0.01%-5.96%+58.36%+108.23% 1,034B
+1.48%+0.76%+55.34%+71.49% 654B
+0.67%-1.53%+24.39%+76.60% 459B
+0.49%-6.58%+34.20%+34.59% 343B
+0.27%+2.32%+29.33%+46.97% 307B
+0.12%-4.01%+1.06%+11.93% 251B
+1.08%+0.14%+53.92%+72.51% 237B
+2.64%-2.00%-17.38%-53.64% 202B
-0.21%+0.56%+32.43%+95.19% 186B
Average +0.25%-2.75%+23.83%+43.46% 367.19B
Weighted average by Cap. +0.14%-3.31%+39.21%+67.30%

Financials

2024 2025
Net sales 2,205B 1.62B 1.4B 1.32B 1.2B 2.25B 153B 2.26B 15.62B 6.06B 78.41B 6.1B 5.96B 258B 2,451B 1.81B 1.56B 1.47B 1.34B 2.5B 171B 2.52B 17.37B 6.74B 87.18B 6.78B 6.63B 286B
Net income 24.03B 17.69M 15.26M 14.38M 13.1M 24.48M 1.67B 24.67M 170M 66.05M 854M 66.43M 64.98M 2.81B -69.51B -51.18M -44.16M -41.6M -37.9M -70.84M -4.84B -71.37M -492M -191M -2.47B -192M -188M -8.12B
Net Debt 1,042B 767M 662M 624M 568M 1.06B 72.48B 1.07B 7.38B 2.86B 37.06B 2.88B 2.82B 122B 1,394B 1.03B 885M 834M 760M 1.42B 96.96B 1.43B 9.88B 3.83B 49.57B 3.85B 3.77B 163B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
26-09-02 ₩9,850.00 -1.20% 57,057
26-09-01 ₩9,970.00 -0.60% 33,278
26-08-31 ₩10,030.00 -1.08% 36,059
26-08-28 ₩10,140.00 +1.30% 52,878
26-08-27 ₩10,010.00 -2.91% 66,210
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock